Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
ABMD

Abiomed Inc

Biotechnology

The Incredible Technology Saving Critically Ill COVID-19 Patients

September 22, 2020 by Michael A. Robinson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

One of the starkest lessons of the global novel coronavirus pandemic is the need for medicine to start looking at existing drugs and procedures in a new way.

We've already seen the benefits of such an approach. The discovery that remdesivir and dexamethasone – an antiviral and a steroid – could both help save severely ill COVID-19 patients' lives springs right to mind.

But adapting the old to fight the new isn't just limited to drugs. Existing medical technology ("medtech") is being used in entirely new ways, or in situations that would've been unthinkable just 10 or 12 months ago.

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died… Full Story

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died...

Stocks

This Healthcare Stock to Buy Is Set to Absolutely Skyrocket

July 10, 2019 by Money Morning News Team

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The best healthcare stock to buy now is a company that makes life-saving products.

But it also expects earnings to rise more than 100% over the next three years.

This company serves over 100 million people around the world suffering from heart disease annually.

Many of them don't meet the criteria for coronary bypass surgery or transplants due to the high risk.

But that's what puts this company's technology so high in demand.

Read more here...

Stocks

A New Catalyst Is Set to Double This Healthcare Stock's Earnings

June 20, 2019 by Stephen Mack

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The best stocks to buy are those that provide products and services we can’t live without.

So it’s hard to beat this healthcare stock that’s alleviating the world’s No. 1 cause of death, with more than 50,000 patients treated to date.

Find out why now is the best time to invest...

Stocks

Is This the Best Track Record on Wall Street?

May 16, 2018 by Dustin Parrett

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

We turned back the clock to this time five years ago to test the performance of the Money Morning VQScore™ tool. What we found is simply astonishing…

If you bought our top-rated stocks in May 2013, you would have made some serious cash.

In fact, if you know of a hedge fund, Wall Street bank, or even your own financial advisor who matched this record, we'd love to hear about it...

Technology

These 5 Simple Rules - and 5 Stocks - Will Put You on the Road to Wealth in 2018

January 12, 2018 by Stephen Mack

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

2017 was a great year for tech stocks.

2018 could be even better for you if you follow these five simple rules.

Plus, we give you five picks that could put you on the road to wealth this year.

Stocks

Why Apple, ROBO ETF, and Abiomed Are Stocks to Watch Now

September 19, 2017 by Stephen Mack

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Our latest list of stocks to watch now includes a company on the way to a trillion-dollar valuation, an ETF on one of tech's most exciting frontiers, and the maker of the world's smallest heart pump.

Check out the stocks that are shaking up Wall Street today.

Stocks

The Best Stocks to Buy Now: Five Picks to Put You on Tech's Frontier

September 14, 2017 by Stephen Mack

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Our latest round of best stocks to buy now includes five picks that are harnessing the power of technology to ensure their long-term growth.

They include a coffee company that has become the envy of Silicon Valley and a tech giant following in Warren Buffett's footsteps.

Don't miss these high-tech profit opportunities.

biotechnology

This Biotech Stock to Buy Could Double Your Money and Save Thousands of Lives

September 13, 2017 by Money Morning Staff Reports

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Healthcare spending is expected to soar through 2025 to make up 20% of total GDP.

Meanwhile, the massive baby boomer generation will likely be getting old by that year.

To profit from both trends, you should invest in this biotech stock today...

Biotechnology

These 5 Indicators Tell Me This Stock Will Double by 2020

August 28, 2017 by Michael A. Robinson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Jara Herron, the owner of a salon and day spa in Tulsa, Okla., had just given birth to her seventh child about six years ago when she suddenly felt her chest getting tighter.

When she got to the hospital, Herron learned she was having a heart attack. Her organs soon began to fail, so doctors put her into a medical coma.

Because Herron was not a candidate for a heart transplant, her doctors instead turned to the world's smallest heart pump, one that can be inserted with a noninvasive catheter. That heart pump saved Herron's life.

And it's done the same thing for thousands of other patients around the United States.

But that's far from the only thing this innovative heart pump has done.

It's also helped hand investors 569% gains.

Its maker is a cutting-edge medtech firm with deep expertise with heart patients.

Those big gains are just a start for this life sciences leader.

In fact, it's set to double your money in as little as two years...

Latest News

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do

September 14, 2023 • By Tom Gentile

Tulips Are the Secret to Trading the Next 300% Rally in AI

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information